Baxiva Overview
- Headquarters
- Zürich, Ch
- Website
- www.baxiva.com
- Industry
- Biotechnology Research
- Employees
- 5
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Baxiva
Baxiva is developing the first K-antigen-targeting vaccine to prevent E. coli infections, offering the highest level of protection against UTIs and systemic infections.
Baxiva Contact Details
- People in AeroLeads
- 3
Baxiva Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Giorgia Greter | Pioneer Fellow - Cofounder | Zurich, Switzerland |
View
|
| Sharon Dreier |
View
|
||
| Tim Keys | Cso, Baxiva Ag |
View
|
Compare Similar Companies to Baxiva
Novartis
Pharmaceutical Manufacturing
Alfasigma
Pharmaceutical Manufacturing
Nouscom
Biotechnology Research
Araris Biotech AG
Biotechnology Research
Xlife Sciences AG
Biotechnology Research
CellX Biosolutions
Biotechnology Research
Adina Technologies
Nanotechnology Research
ALPIONER Therapeutics
Biotechnology Research
Sciencepreneurship
Think Tanks
APY Therapeutics, LLC
Biotechnology Research